SELZENTRY
These highlights do not include all the information needed to use SELZENTRY safely and effectively. See full prescribing information for SELZENTRY. SELZENTRY (maraviroc) tablets, for oral useSELZENTRY (maraviroc) oral solutionInitial U.S. Approval: 2007
46f30ac5-c96b-429e-976d-8c5ee1c0761b
HUMAN PRESCRIPTION DRUG LABEL
Sep 26, 2022
ViiV Healthcare Company
DUNS: 027295585
Products 6
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
maraviroc
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
maraviroc
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (12)
maraviroc
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
maraviroc
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (12)
maraviroc
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (12)
maraviroc
Product Details
FDA regulatory identification and product classification information